Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like State Street, one of the biggest asset/investment firms in the world now owns 10% of CARA.
I might have to buy back in asap.
Support systems just crashed!!! Danger Mr. Robinson!
Is anything ever going to happen here? 6 month chart so flat.
What do these guys even do? Site is very vague
Ruh Ruh! Based on the 6 month chart, if .45 falls, there's really no support anytime soon to prop it up. This is a critical moment.
Already did, like 5 times haha. Will go hard if it dips below 1.00. Love the John Stewart connection.
4kl;
The slow bleed continues. So regret getting in around $2, but very confident long term. Any thoughts on when the inevitable Canadian MJ pop happens?
Im thinking 3q or 4q, at latest 1q 2018
I figured getting in at half of what Aphria paid and at the 52 week low was a good deal (.26) ): I've averaged down like 5 times, looks to finally have bottomed at .10
Which is crazy low considering they are in phase 2!!!
Well it's pretty obvious there will be a major upswing sometime before next year/legalization starts. Maybe in Fall? Or right befor legalization really kicks in, Spring? Thoughts?
My 3 picks are sprwf, emmbf (which has also been beaten down hard) and twmjf.
Nice post, agreed.
Considering zyne and cara are currently my biggest holdings, i'm having a complete shit day, to say the least.
Very disappointing.
This is BS! Appears to be better than Oxycodone and with little side effects! Makes no sense!
On very light volume at least. Results looked fine to me, just not a slam dunk. 21% is a crazy over reaction, wtf? We're people expecting the cure to cancer, aids and pain rolled into one?
I'm assuming because only the highest dose made a difference, but 39% had major pain reduction and with only dry mouth and constipation? Not shabby at all.
God damnit. Tanking on decent news. No wonder i'm going bald.
$CARA institutional ownership up to a whopping 55%!!! WOW!
http://www.nasdaq.com/symbol/cara/institutional-holdings
I hear ya. Can you imagine Aphria? They are down a couple million at this point. Yikes!
Should be out by Friday (last day of quarter)
"Top-line data from a Phase 2b trial of Oral CR845 in chronic pain associated with osteoarthritis are expected in the second quarter of 2017."
Should be out by Friday, most likely tomorrow or thursday pr
Will they ever let these breathe? From +7% to +2% in an hour. Let it run for F*cks sake
Thinking another 5-10% tomorrow. 10-30% if results come in before market (and they are good obviously)
And on the Russel 3000
http://zynerba.com/zynerba-pharmaceuticals-added-russell-3000-index/
Making power moves, phase 2 coming quick!
http://zynerba.com/zynerba-pharmaceuticals-initiates-zyn001-phase-1-clinical-program/
I really missed the mark on this one. Praying for a rebound, if .10 falls might have to sell at a major loss. ):
Looking very solid! Hold tights lads, more news this week!
I pity the fool that sells this week, before results are released. IMHO there is no way the results are bad, if they we're they would have held off releasing the FDA news till after to soften the blow.
This is a slam dunk, if I had more funds I would be adding.
Probably keep getting manipulated in this range till mid July, then it should get interesting quick.
Excellent interview. Cara could be the ONE!
There is a very good chance results will be posted Monday. The stars are aligning.
I'm thinking $25-$30 next week, if results are good, which I expect they will be. I highly doubt they would release all this good news this week just to release bad results next week.
What a great close! The $6 shares in my IRA are looking lovely.
Huh? 180 million? The float is barely 30 Million.
There is more news next week though. This isn't a 'sell the news" type pf stock IMO. This is a hold for FDA approval, life changing stock.
https://www.fool.com/investing/2017/06/22/forget-cancer-drug-stocks-heres-a-little-biotech-t.aspx
"Results from two important trials for pain indications are due by the end of this month. Top line data for a phase 2b trial of the oral formulation for osteoarthritis is due out any day now."
This stock is so easy to manipulate and has major fluctuations due to it's extremely low float. Even after raising funds the OS is a measly 10.6M.
I can't wait for shorts to be burned in late July or August.
Seems like a lot of people are forgetting they are releasing results for the chronic pain studies next week. The news yesterday was just a teaser.
Throwing salt in the wound bro, we get it.
I'm locked and loaded, looking forward to both results. If memory serves me, CR845 was dosed up to 5 times as much as needed to prove safety and tolerability.